Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
28 Nov, 2022 (Monday)

            
CHINA STATE CON(3311)
Analysis:
In the face of the COVID-19 pandemic outbreak, China State Construction International (3311) persists in advancing its business transformation strategy by centering on superior markets such as the Yangtze River Delta and the Greater Bay Area, continuing to secure infrastructure investment projects with short duration and fast turnover, and expanding its featured general contracting business through differentiated competencies. For the nine months ended 30 September 2022, the unaudited Group revenue and share of revenue of joint ventures of the Group were approximately HK$73,411,573,000 and HK$2,638,729,000 respectively, representing YoY growth of 38.9% and 182.4%, while the aggregate amount of unaudited operating profit and the share of profits of joint ventures was approximately HK$9,828,671,000, representing YoY growth of 17.4%. The Group recorded an accumulated new contract value of approximately HK$125.74 billion for the nine months ended 30 September. As of 30 September 2022, the Group recorded a backlog of approximately HK$299.18 billion. (I do not hold the above stock)
Strategy:
Buy-in Price: $8.70, Target Price: $9.60, Cut Loss Price: $8.30


HR(600276)
Analysis:
As one of the most innovative large-scale pharmaceutical enterprises in China, Hengrui Pharmaceutical is the largest research and production base of anti-tumor drugs and surgical drugs in China. From 2019 to 2022, the company suffered from multiple impacts of centralized purchase and epidemic, and its performance and valuation suffered setbacks; With the "centralized purchase clearing+innovation cashing+international breakthrough", the company will enter a new stage of stable growth. At present, the company has nearly listed 18 innovative drugs. While deeply cultivating the traditional field, it also expands the high potential blue ocean fields such as autoimmunization and ophthalmology. SHR1701 (PD-L1/TGF β Double target fusion protein), MIL62 (CD20 monoclonal antibody), Retagliptin (DPP4 inhibitor), SHR1209 (PCSK9 monoclonal antibody), SHR7280 (GnRH inhibitor), A1811 (HER2-ADC) are expected to become new heavy weight varieties. The achievements of the self built R&D platform were realized, and many FIC target drugs entered the early clinical stage. With the smooth progress of the products in Phase I and Phase II clinical research, the sales of innovative drugs will further increase.
Strategy:
Buy-in Price: RMB37.50, Target Price: RMB44.00, Cut Loss Price: RMB34.00



Baguio Green (1397.HK) - Core cleaning services recorded a considerable growth in 1H2022, contracts on hand recorded historical high

Originated in 1980, Baguio Green Group (“Baguio”) has developed into a group of providing integrated environmental services, ranging from Professional Cleaning, Recycling, Waste Management and Collection, Horticulture and Landscaping, and Integrated Pest Management. The company's main business is mainly divided into four segments, including: (1) Cleaning services business; (2) Waste management and recycling business; (3) Landscaping services business; and (4) Pest management business, customers cover all walks of life and different Types of institutions, such as HKSAR Government, public utilities, and private corporations.

Core cleaning services recorded a considerable growth in 1H2022

For the six months ended 30 June 2022 (1H2022), revenue amounted to HK$714.1mn, representing an increase of 21.6% YoY. The increase was mainly due to the increase in revenue in cleaning segment with increase in number of contracts and orders during the Period. Net profit attributable to equity shareholders for the period amounted to HK$17.8mn (1H2021: HK$12.2mn), representing an increase of 45.3% YoY. Basic EPS was HK$4.29 cents (1H2021: HK$2.95 cents), with no interim dividend.

The gross profit for the period was HK$57.7 million, representing an increase of 17.6% YoY. Though there was a strong performance in cleaning segment which were partially offset by the initial operation costs from new projects in waste and recycling segment. The overall gross profit margin dropped from 8.4% to 8.1% mainly due to the initial operation costs in our new projects in waste and recycling segment. Relevant income in short run may not proportional to expenditure. In additions, the progress delay of landscaping projects and high service level demand in pest management services market with keen competition, together with the high energy price also affected the gross profit margin.

By business segment, cleaning services recorded a considerable growth in 1H2022. Revenue of cleaning services increased by 42% to HK$498.6mn, accounting for 69.8% of the overall revenue. secured a number of new service contracts from the HKSAR Government worth HK$1.6 billion. Demand for cleaning services increased due to the pandemic. Specifically, high profit margin cleaning services, such as disinfection and cleaning services for quarantine hotels, greatly contributed to the overall growth in our cleaning business and an increase in gross profit margin to 9.7% from 7.4%.

With regard to the waste management and recycling business, revenue slightly decreased by 4.9% to HK$111.8mn, accounting for 15.7% of the overall revenue. Company is contracted by the EPD to handle over 5,000 recycling spots (including plastic, glass bottles, metals and waste paper) across HK and currently operate various sorting facilities to support recycling business. Baguio is also the operator contracted by the EPD to manage three-colour recycling bins in the HK Island, Kowloon and New Territories. In Jan-2022, it won a new 33-month EPD Plastic Recycling Pilot Scheme contract to provide plastic collection services for three districts (Eastern, Kwun Tong and Central & Western). Baguio also provides plastic collection services for Recycling Stations and Reverse Vending Machines, which were introduced by EPD and other institutions in HK. In addition, the Baguio also provides collection and management services of glass bottles for the HK Island (including Islands District) and the New Territories. During the Period, the gross profit margin declined 8.4 percentage points to 3.0% due to various factors including increasing energy prices and inflation combined with a decline in the recycling rate during the pandemic., the overall decline was mainly due to the impact of our plastic recycling services. Under the EPD's Plastic Recycling Pilot Scheme, the contractor needed to invest substantial resources and costs to initiate and establish the collection network in the first half of the year. Revenue generated in the short run may not be proportional to expenditure. Management stated in the report that it is expected after the contract has commenced for a certain period of time, this short-term disproportionate issue will be improved.

In the landscaping services, revenue decreased by 9.2% to HK$56.9mn, accounting for 8.0% of the overall revenue. Projects continued to experience delays with increased logistics costs due to the ongoing pandemic, the gross profit margin declined 0.7 percentage points to 6.7%. Additionally, intense market competition affected the gross profit margin and the overall performance.

For the pest management business, revenue decreased by 15.1% to HK$46.8mn, accounting for 6.5% of the overall revenue. Since the outbreak of COVID-19 pandemic, the entry of newcomers has led to keen competition affecting the gross profit margin declined 4.3 percentage points to 4.6%.

As of 30 June 2022, new contracts awarded to the company amounted to a total of HK$1950mn. As a result, company recorded a historical high for its contracts on hand of HK$3406mn, representing an increase of 59% YoY. Among which, HK$900mn would be recognized by the end of 2022; HK$1,328mn would be recognized in 2023 and the rest of HK$1,178mn would be recognized in 2024 and beyond.

Investment Thesis

With the Municipal Solid Waste (MSW) Charging Scheme scheduled to be launched in the second half of 2023, it is expected to further motivate the public to recycle and to increase the recycling volume. With the implementation of the Producer Responsibility Scheme on Plastic Beverage Containers enshrining the principle of “polluter pays” and the vision of “eco-responsibility”, the recycling rate of plastic beverage containers is expected to have a significant increase. The two schemes are expected to directly drive the growth of Baguio's recycling business and create better returns. We expect FY2022E-FY2023E EPS to be HKD8.22 cents and HKD9.28 cents respectively, with PT of HKD0.67, implies a FY2022E P/E of 8.2x (~2-yrs historical average). Our investment rating is “Buy”.

Risk factors

1) Market competition intensifies; 2) Soaring in operating cost; and 3) Unexpected slowdown in service demand.

Financial

Click Here for PDF format...




Recommendation on 28-11-2022
RecommendationBuy
Price on Recommendation Date$ 0.445
Suggested purchase priceN/A
Target Price$ 0.670
Writer Info
Eric Li
(Research Analyst)
Tel: (+852 2277 6516)
Email:
erichyli@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2022 Phillip Securities (HK) Ltd. All Rights Reserved.